Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)
Clinical trial NCT00984620 · COMPLETED
Trial details
- NCT number
- NCT00984620
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2011-04-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.